CWH Capital Management Inc. Has $504000 Position in Stryker Corporation (NYSE:SYK)

Paterniano Del Favero
Agosto 10, 2017

Fundsmith LLP now owns 5,175,453 shares of the medical technology company's stock worth $681,348,000 after buying an additional 226,057 shares during the last quarter. Earnest Prtnrs Ltd Company invested 0% of its portfolio in Stryker Corporation (NYSE:SYK).

A number of other hedge funds and other institutional investors also recently bought and sold shares of SYK. Intercontinental Wealth Advisors LLC acquired a new stake in Stryker Corporation during the second quarter valued at approximately $347,000. Blue Chip Partners Inc. now owns 1,775 shares of the medical technology company's stock worth $234,000 after buying an additional 6 shares in the last quarter. SG Americas Securities LLC boosted its position in shares of Stryker Corporation by 600.6% in the first quarter. The Suffolk Capital Management Llc holds 140,760 shares with $16.19M value, up from 132,692 last quarter. The Massachusetts-based Martingale Asset Ltd Partnership has invested 0.43% in Stryker Corporation (NYSE:SYK). British Columbia Investment Management Corp now owns 133,596 shares of the medical technology company's stock worth $17,588,000 after buying an additional 12,871 shares in the last quarter. Independent Order Of Foresters has 0.26% invested in Stryker Corporation (NYSE:SYK). Guardian Life Insurance Co. of America now owns 1,199 shares of the medical technology company's stock worth $158,000 after buying an additional 9 shares during the last quarter. 1,080,989 shares of the stock traded hands.

Stryker Corporation (SYK) traded down 0.66% during trading on Wednesday, hitting $145.18. The stock's 50 day moving average is $143.16 and its 200-day moving average is $134.68. The stock stands almost $2.36 off versus the 52-week high of $148.84 and $40 above the 52-week low of $106.48.

The company's P/E ratio is 32.67 and market capitalization is 54.75B.

Stryker Corporation (NYSE:SYK) last issued its earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.51 by $0.02. The business had revenue of $3.01 billion for the quarter, compared to the consensus estimate of $2.98 billion. Stryker Corporation had a net margin of 14.22% and a return on equity of 24.26%. The firm's revenue for the quarter was up 6.1% on a year-over-year basis. During the same period in the previous year, the business earned $1.39 earnings per share. Analysts expect that Stryker Corporation will post $6.50 EPS for the current fiscal year. Shareholders of record on Friday, September 29th will be paid a dividend of $0.425 per share. This represents a $1.70 dividend on an annualized basis and a dividend yield of 1.16%. The ex-dividend date is set for Wednesday the 28th of June 2017. Stryker Corporation's payout ratio is 37.95%.

ILLEGAL ACTIVITY NOTICE: This report was first posted by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this news story on another website, it was copied illegally and republished in violation of USA and global copyright law.

More important recent Union Pacific Corporation (NYSE:UNP) news were published by: Nasdaq.com which released: "Union Pacific (UNP) Q2 Earnings: Another Beat in Store?" on July 17, 2017, also Seekingalpha.com published article titled: "Union Pacific Is Worth About $70 Per Share", Seekingalpha.com published: "Union Pacific: Driving Toward Our Worst-Case Valuation" on July 25, 2017.

SYK has been the topic of a number of recent analyst reports. BidaskClub lowered Stryker Corporation from a "buy" rating to a "hold" rating in a research report on Monday, July 31st. Oppenheimer Holdings, Inc. reissued a "hold" rating on shares of Stryker Corporation in a research note on Monday, June 19th. Zacks Investment Research raised Stryker Corporation from a "hold" rating to a "buy" rating and set a $166.00 price objective on the stock in a research note on Tuesday, August 1st. Cantor Fitzgerald began coverage on shares of Stryker Corporation in a research note on Thursday, June 29th. They set a "neutral" rating and a $153.00 price target on the stock. Finally, Morgan Stanley reiterated an "overweight" rating and issued a $160.00 target price (up from $155.00) on shares of Stryker Corporation in a research note on Monday, July 10th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and twelve have given a buy rating to the stock. The company now has an average rating of "Hold" and a consensus price target of $144.03.

In other Stryker Corporation news, insider Lonny J. Carpenter sold 5,000 shares of the stock in a transaction dated Friday, August 4th. The shares were sold at an average price of $146.36, for a total transaction of $731,800.00. Following the completion of the sale, the insider now owns 88,207 shares in the company, valued at approximately $12,909,976.52. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Becker Yin C also sold $550,935 worth of Stryker Corporation (NYSE:SYK) on Wednesday, February 15. The stock was sold at an average price of $144.56, for a total transaction of $2,790,730.80.

Group President, Orthopaedics David Floyd disclosed the sale of 19,305 shares of (SYK). Over the last quarter, insiders have sold 31,686 shares of company stock worth $4,590,562. When it comes to ownership structure of a company, the impact has been observed in both the long-and short-term performance of shares. Fca Tx has 1.1% invested in Stryker Corporation (NYSE:SYK). The Firm offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Business's segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other.

Altre relazioni OverNewsmagazine

Discuti questo articolo

SEGUI I NOSTRI GIORNALE